FIRST AMENDMENT TO NOTE PURCHASE AGREEMENTNote Purchase Agreement • August 11th, 2022 • RVL Pharmaceuticals PLC • Pharmaceutical preparations • New York
This NOTE PURCHASE AGREEMENT is entered into as of October 1, 2021 among OSMOTICA PHARMACEUTICAL CORP., a Delaware corporation (the “Issuer”), RVL HOLDINGS US LLC, a Delaware limited liability company (“Intermediate Holdings”), RVL PHARMACEUTICALS PLC, an Irish public limited company (“Super Holdings”), the Guarantors (defined herein), the Purchasers (defined herein) and ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, as the Administrative Agent.
SHARE SUBSCRIPTION AGREEMENTShare Subscription Agreement • August 11th, 2022 • RVL Pharmaceuticals PLC • Pharmaceutical preparations • New York
This Share Subscription Agreement (this “Agreement”) is dated as of August 4, 2022 (the “Effective Date”), by and between RVL Pharmaceuticals plc, a public limited company incorporated under the laws of Ireland (the “Company”), and Avista Healthcare Partners, L.P., a Bermuda limited partnership (the “Purchaser”).
